Cargando…

Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants

The rapid spread of SARS-CoV-2 variants in the global population is indicative of the development of selective advantages in emerging virus strains. Here, we performed a case-control investigation of the clinical and demographic characteristics, clinical history, and virological markers to predict d...

Descripción completa

Detalles Bibliográficos
Autores principales: Selvavinayagam, Sivaprakasam T., Yong, Yean Kong, Joseph, Narcisse, Hemashree, Kannan, Tan, Hong Yien, Zhang, Ying, Rajeshkumar, Manivannan, Kumaresan, Anandhazhvar, Kalpana, Raghu, Kalaivani, Vasudevan, Monika, Ayyagari Venkata Devi, Suvaithenamudhan, Suvaiyarasan, Kannan, Meganathan, Murugesan, Amudhan, Narayanasamy, Krishnasamy, Palani, Sampath, Larsson, Marie, Shankar, Esaki M., Raju, Sivadoss
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540788/
https://www.ncbi.nlm.nih.gov/pubmed/36211690
http://dx.doi.org/10.3389/fpubh.2022.1018399
_version_ 1784803780130242560
author Selvavinayagam, Sivaprakasam T.
Yong, Yean Kong
Joseph, Narcisse
Hemashree, Kannan
Tan, Hong Yien
Zhang, Ying
Rajeshkumar, Manivannan
Kumaresan, Anandhazhvar
Kalpana, Raghu
Kalaivani, Vasudevan
Monika, Ayyagari Venkata Devi
Suvaithenamudhan, Suvaiyarasan
Kannan, Meganathan
Murugesan, Amudhan
Narayanasamy, Krishnasamy
Palani, Sampath
Larsson, Marie
Shankar, Esaki M.
Raju, Sivadoss
author_facet Selvavinayagam, Sivaprakasam T.
Yong, Yean Kong
Joseph, Narcisse
Hemashree, Kannan
Tan, Hong Yien
Zhang, Ying
Rajeshkumar, Manivannan
Kumaresan, Anandhazhvar
Kalpana, Raghu
Kalaivani, Vasudevan
Monika, Ayyagari Venkata Devi
Suvaithenamudhan, Suvaiyarasan
Kannan, Meganathan
Murugesan, Amudhan
Narayanasamy, Krishnasamy
Palani, Sampath
Larsson, Marie
Shankar, Esaki M.
Raju, Sivadoss
author_sort Selvavinayagam, Sivaprakasam T.
collection PubMed
description The rapid spread of SARS-CoV-2 variants in the global population is indicative of the development of selective advantages in emerging virus strains. Here, we performed a case-control investigation of the clinical and demographic characteristics, clinical history, and virological markers to predict disease progression in hospitalized adults for COVID-19 between December 2021 and January 2022 in Chennai, India. COVID-19 diagnosis was made by a commercial TaqPath COVID-19 RT-PCR, and WGS was performed with the Ion Torrent Next Generation Sequencing System. High-quality (<5% of N) complete sequences of 73 Omicron B.1.1.529 variants were randomly selected for phylogenetic analysis. SARS-CoV-2 viral load, number of comorbidities, and severe disease presentation were independently associated with a shorter time-to-death. Strikingly, this was observed among individuals infected with Omicron BA.2 but not among those with the BA.1.1.529, BA.1.1, or the Delta B.1.617.2 variants. Phylogenetic analysis revealed severe cases predominantly clustering under the BA.2 lineage. Sequence analyses showed 30 mutation sites in BA.1.1.529 and 33 in BA.1.1. The mutations unique to BA.2 were T19I, L24S, P25del, P26del, A27S, V213G, T376A, D405N and R408S. Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and the Omicron BA.1.1.529 variant but not with Omicron BA.1.1 or BA.2 suggests that the newer strains are largely immune escape variants. The number of vaccine doses received was independently associated with increased odds of developing asymptomatic disease or recovery. We propose that the novel mutations reported herein could likely bear a significant impact on the clinical characteristics, disease progression, and epidemiological aspects of COVID-19. Surging rates of mutations and the emergence of eclectic variants of SARS-CoV-2 appear to impact disease dynamics.
format Online
Article
Text
id pubmed-9540788
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95407882022-10-08 Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants Selvavinayagam, Sivaprakasam T. Yong, Yean Kong Joseph, Narcisse Hemashree, Kannan Tan, Hong Yien Zhang, Ying Rajeshkumar, Manivannan Kumaresan, Anandhazhvar Kalpana, Raghu Kalaivani, Vasudevan Monika, Ayyagari Venkata Devi Suvaithenamudhan, Suvaiyarasan Kannan, Meganathan Murugesan, Amudhan Narayanasamy, Krishnasamy Palani, Sampath Larsson, Marie Shankar, Esaki M. Raju, Sivadoss Front Public Health Public Health The rapid spread of SARS-CoV-2 variants in the global population is indicative of the development of selective advantages in emerging virus strains. Here, we performed a case-control investigation of the clinical and demographic characteristics, clinical history, and virological markers to predict disease progression in hospitalized adults for COVID-19 between December 2021 and January 2022 in Chennai, India. COVID-19 diagnosis was made by a commercial TaqPath COVID-19 RT-PCR, and WGS was performed with the Ion Torrent Next Generation Sequencing System. High-quality (<5% of N) complete sequences of 73 Omicron B.1.1.529 variants were randomly selected for phylogenetic analysis. SARS-CoV-2 viral load, number of comorbidities, and severe disease presentation were independently associated with a shorter time-to-death. Strikingly, this was observed among individuals infected with Omicron BA.2 but not among those with the BA.1.1.529, BA.1.1, or the Delta B.1.617.2 variants. Phylogenetic analysis revealed severe cases predominantly clustering under the BA.2 lineage. Sequence analyses showed 30 mutation sites in BA.1.1.529 and 33 in BA.1.1. The mutations unique to BA.2 were T19I, L24S, P25del, P26del, A27S, V213G, T376A, D405N and R408S. Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and the Omicron BA.1.1.529 variant but not with Omicron BA.1.1 or BA.2 suggests that the newer strains are largely immune escape variants. The number of vaccine doses received was independently associated with increased odds of developing asymptomatic disease or recovery. We propose that the novel mutations reported herein could likely bear a significant impact on the clinical characteristics, disease progression, and epidemiological aspects of COVID-19. Surging rates of mutations and the emergence of eclectic variants of SARS-CoV-2 appear to impact disease dynamics. Frontiers Media S.A. 2022-09-20 /pmc/articles/PMC9540788/ /pubmed/36211690 http://dx.doi.org/10.3389/fpubh.2022.1018399 Text en Copyright © 2022 Selvavinayagam, Yong, Joseph, Hemashree, Tan, Zhang, Rajeshkumar, Kumaresan, Kalpana, Kalaivani, Monika, Suvaithenamudhan, Kannan, Murugesan, Narayanasamy, Palani, Larsson, Shankar and Raju. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Selvavinayagam, Sivaprakasam T.
Yong, Yean Kong
Joseph, Narcisse
Hemashree, Kannan
Tan, Hong Yien
Zhang, Ying
Rajeshkumar, Manivannan
Kumaresan, Anandhazhvar
Kalpana, Raghu
Kalaivani, Vasudevan
Monika, Ayyagari Venkata Devi
Suvaithenamudhan, Suvaiyarasan
Kannan, Meganathan
Murugesan, Amudhan
Narayanasamy, Krishnasamy
Palani, Sampath
Larsson, Marie
Shankar, Esaki M.
Raju, Sivadoss
Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
title Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
title_full Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
title_fullStr Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
title_full_unstemmed Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
title_short Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
title_sort low sars-cov-2 viral load among vaccinated individuals infected with delta b.1.617.2 and omicron ba.1.1.529 but not with omicron ba.1.1 and ba.2 variants
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540788/
https://www.ncbi.nlm.nih.gov/pubmed/36211690
http://dx.doi.org/10.3389/fpubh.2022.1018399
work_keys_str_mv AT selvavinayagamsivaprakasamt lowsarscov2viralloadamongvaccinatedindividualsinfectedwithdeltab16172andomicronba11529butnotwithomicronba11andba2variants
AT yongyeankong lowsarscov2viralloadamongvaccinatedindividualsinfectedwithdeltab16172andomicronba11529butnotwithomicronba11andba2variants
AT josephnarcisse lowsarscov2viralloadamongvaccinatedindividualsinfectedwithdeltab16172andomicronba11529butnotwithomicronba11andba2variants
AT hemashreekannan lowsarscov2viralloadamongvaccinatedindividualsinfectedwithdeltab16172andomicronba11529butnotwithomicronba11andba2variants
AT tanhongyien lowsarscov2viralloadamongvaccinatedindividualsinfectedwithdeltab16172andomicronba11529butnotwithomicronba11andba2variants
AT zhangying lowsarscov2viralloadamongvaccinatedindividualsinfectedwithdeltab16172andomicronba11529butnotwithomicronba11andba2variants
AT rajeshkumarmanivannan lowsarscov2viralloadamongvaccinatedindividualsinfectedwithdeltab16172andomicronba11529butnotwithomicronba11andba2variants
AT kumaresananandhazhvar lowsarscov2viralloadamongvaccinatedindividualsinfectedwithdeltab16172andomicronba11529butnotwithomicronba11andba2variants
AT kalpanaraghu lowsarscov2viralloadamongvaccinatedindividualsinfectedwithdeltab16172andomicronba11529butnotwithomicronba11andba2variants
AT kalaivanivasudevan lowsarscov2viralloadamongvaccinatedindividualsinfectedwithdeltab16172andomicronba11529butnotwithomicronba11andba2variants
AT monikaayyagarivenkatadevi lowsarscov2viralloadamongvaccinatedindividualsinfectedwithdeltab16172andomicronba11529butnotwithomicronba11andba2variants
AT suvaithenamudhansuvaiyarasan lowsarscov2viralloadamongvaccinatedindividualsinfectedwithdeltab16172andomicronba11529butnotwithomicronba11andba2variants
AT kannanmeganathan lowsarscov2viralloadamongvaccinatedindividualsinfectedwithdeltab16172andomicronba11529butnotwithomicronba11andba2variants
AT murugesanamudhan lowsarscov2viralloadamongvaccinatedindividualsinfectedwithdeltab16172andomicronba11529butnotwithomicronba11andba2variants
AT narayanasamykrishnasamy lowsarscov2viralloadamongvaccinatedindividualsinfectedwithdeltab16172andomicronba11529butnotwithomicronba11andba2variants
AT palanisampath lowsarscov2viralloadamongvaccinatedindividualsinfectedwithdeltab16172andomicronba11529butnotwithomicronba11andba2variants
AT larssonmarie lowsarscov2viralloadamongvaccinatedindividualsinfectedwithdeltab16172andomicronba11529butnotwithomicronba11andba2variants
AT shankaresakim lowsarscov2viralloadamongvaccinatedindividualsinfectedwithdeltab16172andomicronba11529butnotwithomicronba11andba2variants
AT rajusivadoss lowsarscov2viralloadamongvaccinatedindividualsinfectedwithdeltab16172andomicronba11529butnotwithomicronba11andba2variants